ISIN | LU2041625810 |
---|---|
Valor Number | 49473283 |
Bloomberg Global ID | |
Fund Name | JSS Sustainable Equity - Future Health C EUR acc |
Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
Fund Provider | J. Safra Sarasin Investmentfonds AG |
Representative in Switzerland |
J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00 |
Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs. |
Peculiarities |
Current Price * | 99.64 EUR | 13.06.2025 |
---|---|---|
Previous Price * | 100.14 EUR | 12.06.2025 |
52 Week High * | 114.58 EUR | 30.08.2024 |
52 Week Low * | 94.05 EUR | 10.04.2025 |
NAV * | 99.64 EUR | 13.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 135,849,377 | |
Unit/Share Assets *** | 7,032,193 | |
Trading Information SIX |
YTD Performance | -7.54% |
31.12.2024 - 13.06.2025
31.12.2024 13.06.2025 |
---|---|---|
YTD Performance (in CHF) | -7.71% |
31.12.2024 - 13.06.2025
31.12.2024 13.06.2025 |
1 month | +0.64% |
13.05.2025 - 13.06.2025
13.05.2025 13.06.2025 |
3 months | -6.03% |
13.03.2025 - 13.06.2025
13.03.2025 13.06.2025 |
6 months | -8.83% |
13.12.2024 - 13.06.2025
13.12.2024 13.06.2025 |
1 year | -10.30% |
13.06.2024 - 13.06.2025
13.06.2024 13.06.2025 |
2 years | -11.87% |
13.06.2023 - 13.06.2025
13.06.2023 13.06.2025 |
3 years | -6.26% |
13.06.2022 - 13.06.2025
13.06.2022 13.06.2025 |
5 years | +1.35% |
15.06.2020 - 13.06.2025
15.06.2020 13.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 9.82% | |
---|---|---|
Danaher Corp | 7.04% | |
Lonza Group Ltd | 5.42% | |
Siemens Healthineers AG Registered Shares | 5.23% | |
Sanofi SA | 5.19% | |
Intuitive Surgical Inc | 5.13% | |
Novo Nordisk AS Class B | 4.28% | |
AbbVie Inc | 4.23% | |
argenx SE | 4.16% | |
Zoetis Inc Class A | 3.83% | |
Last data update | 30.04.2025 |
TER | 1.38% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.38% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |